Biomaterial Database

Antimicrobial effect of beta-lactam antibiotic combinations against Bacteroides fragilis in vitro. 1983

M B Bansal, and H Thadepalli

Carbenicillin, piperacillin, and mezlocillin, when combined with cefoxitin, exhibited synergism against 20, 13, and 10 isolates of Bacteroides fragilis, respectively, and no antagonism was observed in 19 of 20 strains. These results suggest that if beta-lactamase was induced from B. fragilis by cefoxitin, it was ineffective against the antibiotics tested.

UI	MeSH Term	Description	Entries
D008826	Microbial Sensitivity Tests	Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses).	Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D004357	Drug Synergism	The action of a drug in promoting or enhancing the effectiveness of another drug.	Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D000900	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA.	Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001441	Bacteroides fragilis	Gram-negative bacteria occurring in the lower intestinal tracts of man and other animals. It is the most common species of anaerobic bacteria isolated from human soft tissue infections.
D047090	beta-Lactams	Four-membered cyclic AMIDES, best known for the PENICILLINS based on a bicyclo-thiazolidine, as well as the CEPHALOSPORINS based on a bicyclo-thiazine, and including monocyclic MONOBACTAMS. The BETA-LACTAMASES hydrolyze the beta lactam ring, accounting for BETA-LACTAM RESISTANCE of infective bacteria.	beta-Lactam,4-Thia-1-Azabicyclo(3.2.0)Heptanes,4-Thia-1-Azabicyclo(4.2.0)Octanes,beta Lactam,beta Lactams

Related Publications

M B Bansal, and H Thadepalli

Activity of combinations of antimicrobial agents against Bacteroides fragilis.

March 1976, The Journal of infectious diseases,

M B Bansal, and H Thadepalli

Activity of beta-lactam antimicrobial agents against clinical isolates of Bacteroides fragilis in Kuwait.

February 1998, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases,

M B Bansal, and H Thadepalli

Potentially synergistic antimicrobial combinations with metronidazole against Bacteroides fragilis.

March 1980, Antimicrobial agents and chemotherapy,

M B Bansal, and H Thadepalli

Bactericidal activities of new beta-lactam antibiotics against Bacteroides fragilis.

July 1983, Antimicrobial agents and chemotherapy,

M B Bansal, and H Thadepalli

[Comparative effect of apalcillin and other beta-lactam antibiotics against the Bacteroides fragilis group].

June 1989, Pathologie-biologie,

M B Bansal, and H Thadepalli

Activity of newer beta-lactam agents against clinical isolates of Bacteroides fragilis and other Bacteroides species.

December 1987, Antimicrobial agents and chemotherapy,